Scavenger receptor A1 is required for sensing HCMV by endosomal TLR-3/-9 in monocytic THP-1 cells

Molecular Immunology

Volumn 47, Issue 4, 2010, Pages 883-893

  Yew, Kok Hooi ^a,b   Carsten, Bonnie ^a   Harrison, Christopher ^a,b  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

HCMV; IFN ; IL 12p35; SR A1; THP 1; TLR 2 3 9; TNF

Indexed keywords

BETA INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 12P35; SCAVENGER RECEPTOR A; SCAVENGER RECEPTOR A1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; MONOCYTE; MONOCYTIC THP1 CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIBODIES, BLOCKING; CELL LINE; CYTOKINES; CYTOMEGALOVIRUS; ENDOSOMES; HUMANS; INFLAMMATION; MALE; MODELS, IMMUNOLOGICAL; MONOCYTES; OLIGONUCLEOTIDES, ANTISENSE; SCAVENGER RECEPTORS, CLASS A; SIGNAL TRANSDUCTION; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 9;

HUMAN HERPESVIRUS 5;

EID: 72949091663     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.10.009     Document Type: Article

References (44)

1. Amiel E., Alonso A., Uematsu S., Akira S., Poynter M.E., and Berwin B. Toll-like receptor regulation of scavenger receptor-A-mediated phagocytosis. J. Leukoc. Biol. 85 April (4) (2008) 595-605
2. Azam A.Z., Vial Y., Fawer C.L., Zufferey J., and Hohlfeld P. Prenatal diagnosis of congenital cytomegalovirus infection. Obstet. Gynecol. 97 March (3) (2001) 443-448
3. Barton G.M., and Medzhitov R. Toll-like receptors and their ligands. Curr. Top. Microbiol. Immunol. 270 (2002) 81-92
4. Becker M., Cotena A., Gordon S., and Platt N. Expression of the Class A macrophage scavenger receptor on specific subpopulations of murine dendritic cells limits their endotoxin response. Eur. J. Immunol. 36 April (4) (2006) 950-960
5. Bowdish, D.M., Sakamoto, K., Kim M.J., Kroos, M., Mukhopadhyay, S., Leifer, C.A., Tryggvason, K., Gordon, S., Russell, D.G., 2009. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog. 5(6):e1000474. Epub 2009 Jun 12.
6. Carlquist J.F., Muhlestein J.B., Horne B.D., Hart N.I., Lim T., Habashi J., Anderson J.G., and Anderson J.L. Cytomegalovirus stimulated mRNA accumulation and cell surface expression of the oxidized LDL scavenger receptor, CD36. Atherosclerosis 177 November (1) (2004) 53-59
7. Chatterjee A., Harrison C.J., Britt W.J., and Bewtra C. Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs. J. Infect. Dis. 183 June (11) (2001) 1547-1553
8. Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., and Finberg R.W. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77 April (8) (2003) 4588-4596
9. de la Hoz R.E., Stephens G., and Sherlock C. Diagnosis and treatment approaches of CMV infections in adult patients. J. Clin. Virol. 25 August (Suppl. 2) (2002) S1-S12
10. Dunne D.W., Resnick D., Greenberg J., Krieger M., and Joiner K.A. The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc. Natl. Acad. Sci. U.S.A. 91 March (5) (1994) 1863-1867
11. Emile Gras J.C., Verkuijlen P., Frants R.R., Havekes L.M., van Berkel T.J., Biessen E.A., and van Dijk K.W. Specific and efficient targeting of adenovirus vectors to macrophages: application of a fusion protein between an adenovirus-binding fragment and avidin, linked to a biotinylated oligonucleotide. J. Gene. Med. 8 June (6) (2006) 668-678
12. Fish K.N., Soderberg-Naucler C., Mills L.K., Stenglein S., and Nelson J.A. Human cytomegalovirus persistently infects aortic endothelial cells. J. Virol. 72 July (7) (1998) 5661-5668
13. Gredmark S., Tilburgs T., and Söderberg-Nauclér C. Human cytomegalovirus inhibits cytokine-induced macrophage differentiation. J. Virol. 78 October (19) (2004) 10378-10389
14. Harrison C.J., and Caruso N. Correlation of maternal and pup NK-like activity and TNF responses against cytomegalovirus to pregnancy outcome in inbred guinea pigs. J. Med. Virol. 60 February (2) (2000) 230-236
15. Ibanez C.E., Schrier R., Ghazal P., Wiley C., and Nelson J.A. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65 December (12) (1991) 6581-6588
16. Jin H., Wang X., and Li S. Human cytomegalovirus glycoprotein B genotype correlates with different symptoms of infected infants. Intervirology 50 3 (2007) 219-223
17. Kowalik T.F., Wing B., Haskill J.S., Azizkhan J.C., Baldwin Jr. A.S., and Huang E.S. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc. Natl. Acad. Sci. U.S.A. 90 February (3) (1993) 1107-1111
18. Kumazaki K., Ozono K., Yahara T., Wada Y., Suehara N., Takeuchi M., and Nakayama M. Detection of cytomegalovirus DNA in human placenta. J. Med. Virol. 68 November (3) (2002) 363-369
19. LaMarca H.L., Sainz Jr. B., and Morris C.A. Permissive human cytomegalovirus infection of a first trimester extravillous cytotrophoblast cell line. Virol. J. Nov 17 (1) (2004) 8
20. Landolfo S., Gariglio M., Gribaudo G., and Lembo D. The human cytomegalovirus. Pharmacol. Ther. 98 June (3) (2003) 269-297
21. Lazzarotto T., Varani S., Guerra B., Nicolosi A., Lanari M., and Landini M.P. Prenatal indicators of congenital cytomegalovirus infection. J. Pediatr. 137 July (1) (2000) 90-95
22. Maciejewski J.P., Bruening E.E., Donahue R.E., Sellers S.E., Carter C., Young N.S., and St Jeor S. Infection of mononucleated phagocytes with human cytomegalovirus. Virology 195 August (2) (1993) 327-336
23. Maciejewski J.P., and St Jeor S.C. Human cytomegalovirus infection of human hematopoietic progenitor cells. Leuk. Lymphoma 33 March (1-2) (1999) 1-13
24. Miki S., Tsukada S., Nakamura Y., Aimoto S., Hojo H., Sato B., Yamamoto M., and Miki Y. Functional and possible physical association of scavenger receptor with cytoplasmic tyrosine kinase Lyn in monocytic THP-1-derived macrophages. FEBS Lett. 399 December (3) (1996) 241-244
25. Moore K.J., and Freeman M.W. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler. Thromb. Vasc. Biol. 26 August (8) (2006) 1702-1711
26. Mukhopadhyay S., Peiser L., and Gordon S. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of Class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype. J. Leukoc. Biol. 76 September (3) (2004) 577-584
27. Myerson D., Hackman R.C., Nelson J.A., Ward D.C., and McDougall J.K. Widespread presence of histologically occult cytomegalovirus. Hum. Pathol. 15 May (5) (1984) 430-439
28. O'Brien-Ladner A.R., Nelson M.E., Cowley Jr. B.D., Bailey K., and Wesselius L.J. Hyperoxia amplifies TNF-alpha production in LPS-stimulated human alveolar macrophages. Am. J. Respir. Cell Mol Biol. 12 March (3) (1995) 275-279
29. Oshiumi H., Matsumoto M., Funami K., Akazawa T., and Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4 February (2) (2003) 161-167
30. Pasare C., and Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560 (2005) 11-18
31. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 May (9) (2001) e45
32. Rice P., Kelley J., Kogan G., Ensley H., Kalbfleisch J., Browder I., and Williams D. Human monocyte scavenger receptors are pattern recognition receptors for (1 → 3)-beta-d-glucans. J. Leukoc. Biol. 72 July (1) (2002) 140-146
33. Ryu Y.J., Kim E.J., Lee S.H., Kim S.Y., Suh G.Y., Chung M.P., Kim H., Kwon O.J., and Koh W.J. Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease. Eur. Respir. J. 30 October (4) (2007) 736-742
34. Sano N., and Izumi K. Hepatic cytomegalovirus involvement in autopsy cases. Acta Pathol. Jpn. 41 September (9) (1991) 668-672
35. Smith M.S., Bentz G.L., Alexander J.S., and Yurochko A.D. Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol. 78 May (9) (2004) 4444-4453
36. Speir E., Yu Z.X., and Ferrans V.J. Infectious agents in coronary artery disease: viral infection, aspirin, and gene expression in human coronary smooth muscle cells. Rev. Port. Cardiol. 17 October (Suppl. 2) (1998) II33-II39
37. Stuart L.M., Deng J., Silver J.M., Takahashi K., Tseng A.A., Hennessy E.J., Ezekowitz R.A., and Moore K.J. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 170 August (3) (2005) 477-485
38. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., Mudd S., Shamel L., Sovath S., Goode J., Alexopoulou L., Flavell R.A., and Beutler B. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. U.S.A. 101 March (10) (2004) 3516-3521
39. Taylor-Wiedeman J., Sissons J.G., Borysiewicz L.K., and Sinclair J.H. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72 September (Pt 9) (1991) 2059-2064
40. Tran N., Koch A., Berkels R., Boehm O., Zacharowski P.A., Baumgarten G., Knuefermann P., Schott M., Kanczkowski W., Bornstein S.R., Lightman S.L., and Zacharowski K. Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation. J. Clin. Endocrinol. Metab. 92 July (7) (2007) 2773-2783
41. Tsutsui Y., Kosugi I., and Kawasaki H. Neuropathogenesis in cytomegalovirus infection: indication of the mechanisms using mouse models. Rev. Med. Virol. 15 September-October (5) (2005) 327-345
42. Wang X.Y., Facciponte J., Chen X., Subjeck J.R., and Repasky E.A. Scavenger receptor-A negatively regulates antitumor immunity. Cancer Res. 67 May (10) (2007) 4996-5002
43. Yurochko A.D., Hwang E.S., Rasmussen L., Keay S., Pereira L., and Huang E.S. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J. Virol. 71 July (7) (1997) 5051-5059
44. Zhu, P., Liu, X., Treml, L.S., Cancro, M.P., Freedman, B.D., 2009. Mechanism and regulatory function of CpG signaling via scavenger receptor B1 in primary B Cells. J. Biol. Chem. [Epub ahead of print].